PRTA Q3 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$205,000-19.6% YoY

Gross Profit

-$12M-5990.7% margin

Operating Income

-$21M-10230.2% margin

Net Income

-$19M-9486.8% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+22.8%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$451M

Total Liabilities

$162M

Stockholders' Equity

$289M

Cash & Equivalents

$390M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$205,000	$255,000	-19.6%
Gross Profit	-$12M	-$18M	+32.7%
Operating Income	-$21M	-$24M	+13.8%
Net Income	-$19M	-$25M	+20.8%